Skip to main content

Third Wave Extends Invader Contract With Japanese Reference Lab BML

NEW YORK, Jan. 8 (GenomeWeb News) - Third Wave Technologies has extended its multi-year partnership with BML, a Tokyo-based clinical reference lab, by at least one year, Third Wave said today.

The companies will continue their collaboration, begun in December 2000, to use Third Wave's Invader technology to develop and commercialize molecular diagnostic tests for infectious diseases.

The original agreement the agreement called for BML to pay Third Wave $3 million up front, and provide $4 million in funding for Invader product development over the next three years. In exchange, Third Wave retained the right to market and sell any products developed under the agreement outside Japan, and will later acquire rights to develop and market these products inside Japan.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.